a. ATALAR M., DOĞAN Ö. T., Three Dimensional Thorax Computed Tomography Findings in COVID -19. Erciyes Med. J. 2020; 42 (3).
b. ATASEVEN H., TAŞTEMUR Ş., Is İt Possible to Use Proton Pump Inhibitors in COVID-19 Treament and Prophylaxis? Medical Hypotheses. (Hakem aşamasında).
c. AKTAŞ A., TÜZÜN B., ASLAN R., SAYIN K., ATASEVEN H. New Anti-Viral Drugs For the Treatment of COVID-19 Instead of Favipiravir. Travel Medicine and Infectious Disease. (Hakem aşamasında).
d. AKTAŞ A., TÜZÜN B., TAŞKIN KAFA A.H., SAYIN K., ATASEVEN H. CLARIFICATION OF INTERACTION MECHANISM OF ARBIDOL WITH COVID-19 AND INVESTIGATIONS OF THE INHIBITION ACTIVITY OF ARBIDOL ANALOGUES AGAINST COVID-19. Medical Hypotheses. (Hakem aşamasında).
e. AKTAŞ A., TÜZÜN B., HASBEK M., SAYIN K., ATASEVEN H. Sars-Cov-2 RNA polimerase targeted New Anti-Viral Drugs Instead of chlaritromycin. Travel Medicine and Infectious Disease. (Hakem aşamasında).
f. AKTAŞ A., Can initial platelet/Lymphocyte Raito Predict the Prognosis of tne Patients Under and Over 65 years Diagnosed with Covid-19. Platelet. (Hakem aşamasında).
g. AKTAŞ A., Initial Serum Lactate Levels of Covid-19 Patients Under and Over 65 years. American journal of Emergency Medicine. (Hakem aşamasında).
h. DOĞAN Ö., BUDAK M., KORKMAZ E.M., Phylogenomics inferences and demographic events on the SARS-cov-2 outbreak, PNAS (Hakem aşamasında).
i. AYDEMİR H.B., AYDEMİR M.N., KORKMAZ E.M., ÇEKİN N., PINARBAŞI E. Computational prediction of cellular microRNAs targeting SARS-Cov-2 genome. Journal of Computational Biology (Hakem aşamasında).
j. AYDEMİR H.B., AYDEMİR M.N., KORKMAZ E.M., BUDAK M., PINARBAŞI E. Computational prediction of SARS-Cov-2 microRNAs and their putative pathological functions, Bioinformatics. (Hakem aşamasında)